Unity Biotechnology, Inc. (LON:0YC0)
London · Delayed Price · Currency is GBP · Price in USD 0.1043
-0.0057 (-5.18%)
At close: Jul 17, 2025
Unity Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
1.41M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Unity Biotechnology News
- 7 weeks ago - PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
- 7 weeks ago - This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - Benzinga
- 2 months ago - UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting - GlobeNewsWire
- 3 months ago - Unity Biotechnology GAAP EPS of -$0.43 misses by $0.03 - Seeking Alpha
- 3 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - Benzinga
- 4 months ago - Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls - Benzinga
- 4 months ago - Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls - Benzinga